Statistics Presented for Global Cancer Incidence, Deaths in 2022
By Elana Gotkine HealthDay Reporter
THURSDAY, April 4, 2024 -- In 2022, there were almost 20 million new cases of cancer as well as 9.7 million deaths from cancer, according to a study published online April 4 in CA: A Cancer Journal for Clinicians.
Freddie Bray, Ph.D., from the International Agency for Research on Cancer in Lyon, France, and colleagues present global cancer statistics for 2022 by world region.
The researchers found there were about 20 million new cases of cancer in 2022, including nonmelanoma skin cancers, as well as 9.7 million deaths from cancer. These estimates suggest that about one in five men or women develop cancer in a lifetime, and one in nine men and one in 12 women die from cancer. In 2022, lung cancer was the most frequently diagnosed cancer, responsible for close to 2.5 million new cases (12.4 percent of cancers globally), followed by cancers of the female breast, colorectum, prostate, and stomach (11.6, 9.6, 7.3, and 4.9 percent, respectively). The leading cause of cancer death was lung cancer, with an estimated 1.8 million deaths (18.7 percent), followed by colorectal, liver, female breast, and stomach cancers (9.3, 7.8, 6.9, and 6.8 percent, respectively). In women and men, the most frequent cancers were breast and lung cancer (both cases and deaths). Across world regions, incidence rates varied from fourfold to fivefold for men and women.
"The overall scale of cancer and the diversity of cancer profiles by world region and human development level reemphasize the need for a global escalation of targeted cancer control measures," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted April 2024
Read this next
ACG: 2000 to 2022 Saw Rise in Early-Onset CRC Mortality in the United States
THURSDAY, Oct. 31, 2024 -- Early-onset colorectal cancer (EO-CRC) mortality rose in the United States over the past two decades, most notably in patients aged 20 to 44 years...
Cell-Free Blood DNA Tests Less Effective Than Other CRC Screening
WEDNESDAY, Oct. 30, 2024 -- Cell-free DNA blood tests (cf-bDNA) may be more costly and less effective for colorectal cancer (CRC) screening than other screening modalities...
American College of Surgeons, Oct. 19-22
The annual meeting of the American College of Surgeons was held this year from Oct. 19 to 22 in San Francisco and attracted participants from around the world, including...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.